<DOC>
	<DOCNO>NCT01160822</DOCNO>
	<brief_summary>The purpose study determine whether , patient mild moderate knee osteoarthritis , canakinumab safe tolerable inject intra-articularly .</brief_summary>
	<brief_title>To Determine Safety , Tolerability , Pharmacokinetics Effect Pain Single Intra-articular Administration Canakinumab Patients With Osteoarthritis Knee</brief_title>
	<detailed_description>This randomize , double-blind , parallel group , placebo control 18 week study , consist two part : 1 . Part A : ascending single dose part safety tolerability 4 different canakinumab dos study ( start dose 150 mg , maximum dose 600 mg ) . 2 . Part B : double-dummy , active-controlled , parallel design part pain reduction canakinumab dose select part A study comparison Placebo Naproxen .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>1 . Written informed consent must obtain assessment perform . 2 . Male female patient age 40 80 year ( inclusive ) . 3 . Diagnosis knee osteoarthritis 4 . Radiographic evidence tibiofemoral compartment osteoarthritis 5 . Pain knee last 24 hours.The patient also pain affected knee day last month . 6 . Patients willing discontinue nonsteroidal antiinflammatory drug ( NSAIDs ) analgesic medication take condition , include knee pain , 7 . Patients stable dose opioids least 1 month screening continue take opioid stable dose throughout study . 8 . Patients must also willing abstain intraarticular periarticular injection knee surgery treatment period 9 . Patients , currently take aspirin ( 325 mg/day less ; anticoagulant ) , willing remain stable dose one month prior screen throughout study 1 . Subjects know hypersensitivity biological investigational drug . 2 . Patients contraindication knee injection 3 . Patients joint effusion 4 . Patients rheumatoid arthritis connective tissue like disease 5 . Secondary osteoarthritis history and/or evidence follow disease : septic arthritis , inflammatory joint disease , gout , Paget 's disease bone , articular fracture , major dysplasia congenital abnormality , ochronosis , acromegaly , hemochromatosis , Wilson 's disease , primary osteochondromatosis , juvenile chronic arthritis continue activity adulthood , heritable disorder ( e.g . hypermobility ) . Patients secondary osteoarthritis follow menisectomy injury collateral cruciate ligament exclude . 6 . Presence history underlie metabolic , endocrine , hematologic , pulmonary , cardiac , blood , renal , hepatic , infectious , psychiatric gastrointestinal condition 7 . Evidence tuberculosis ( TB ) 8 . One risk factor TB : 1 . Substance abuse ( e.g . injection noninjection ) 2 . Healthcare worker unprotected exposure patient high risk TB 3 . Patients TB disease identification correct airborne precaution patient 4. close contact ( i.e . share air space household enclose environment prolonged period ( day week , minute hour ) ) person active pulmonary TB disease . 9 . Significant medical problem , include limited following : uncontrolled hypertension , congestive heart failure , uncontrolled diabetes type I II 10 . Subjects evidence hepatic blood coagulation disorder ( i.e . hemophilia , etc ) , anemia , idiopathic thrombocytopenic purpura , gastrointestinal disorder : severe hepatic disease , history alcohol drug abuse ; disease gall bladder pancreas ; active peptic ulceration , gastrointestinal bleed history severe gastroesophageal reflux disease severe hiatus hernia ; inflammatory bowel disease . 11 . Use therapeutic protein drug ( e.g . antitumor necrosis factor alpha ( TNFÎ± ) antibody ) 12 . Presence severe renal function impairment . History renal trauma , glomerulonephritis , patient one kidney , renal failure require regular dialysis treatment . 13 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive pregnancy test ( serum urine ) . 14 . Subjects know contraindication naproxen ( e.g . heart circulation problem , history ulcer disease etc . ) , analgesic , antipyretic , NSAIDs . 15 . Disease spine low extremity joint may interfere assessment target joint . 16 . Surgery knee within last year . Observational arthroscopy , arthroscopic surgery lavage knee within last 6 month . 17 . Use assistive device cane ( walk stick ) knee brace . 18 . Subjects experience , time past , asthma , acute rhinitis , nasal polyp , angioneurotic edema , urticaria allergictype reaction take acetylsalicylic acid ( ASA ) / aspirin NSAIDs . 19 . Any history prior peptic ulcer disease prior NSAID gastrointestinal complication past 5 year . Other protocol define inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Osteo arthritis</keyword>
	<keyword>pain control</keyword>
	<keyword>intra- articular injection</keyword>
	<keyword>Knee OA</keyword>
</DOC>